Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05500274 · ClinicalTrials.gov registry record · NA
Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 778
- Enrollment target
NCT05500274: Completed NA study, sponsored by University of Chicago.
NCT05500274 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 778 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05500274, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 778 participants
- Enrollment target
Study Summary
The "Social network diffusion of COVID-19 prevention for diverse Criminal Legal Involved Communities" study will engage people who have been interacted with law enforcement in COVID-19 prevention (testing and/or vaccination) through social network mobilization combined with theory-driven COVID-19 prevention messaging delivered in an interactive group format. Eligible individuals will be enrolled into a two-arm 1:1 randomized controlled trial design. 800 participants will be enrolled into either a: 1) COVID-19 prevention education arm (Education Arm) or, 2) a network mobilization change agent intervention (Motivational Arm).
Primary Outcome
Number of participants with at least one test within 3 months of baseline.
Interventions
- OTHER Education
- OTHER Motivational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
What the finished NCT05500274 record still lists
NCT05500274 is an interventional study that assigns participants to a tested intervention. The registered 778 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT05500274 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05500274 about?
NCT05500274 is a clinical study titled "Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities". The "Social network diffusion of COVID-19 prevention for diverse Criminal Legal Involved Communities" study will engage people who have been interacted with law enforcement in COVID-19 prevention (testing and/or vaccination) through social network mobilization combined with theory-driven COVID-19 pr...
What is the current status of trial NCT05500274?
This trial is currently completed. It is a NA study. The enrollment target is 778 participants. The study started on 2023-01-10. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05500274?
The interventions under investigation include: Education (OTHER), Motivational (OTHER).
Who is sponsoring clinical trial NCT05500274?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05500274's enrollment target sits among peer trials
778 142nd of 2000 higher than 1,859 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI